Granahan Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Granahan Investment Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-32,875	Closed	-$2.52M	–	249
2016 Q3	$2.52M	Sell	32,875 -1,471	-4%	-$118K	0.08%	175
2016 Q2	$2.95M	Buy	34,346 +5,946	+21%	+$545K	0.11%	177
2016 Q1	$2.63M	Sell	28,400 -255	-0.9%	-$25.5K	0.1%	187
2015 Q4	$5.75M	Sell	28,655 -13,875	-33%	-$2.77M	0.2%	151
2015 Q3	$6.34M	Buy	42,530 +7,250	+21%	+$5.32M	0.2%	162
2015 Q2	$33.5M	Sell	35,280 -759	-2%	-$621K	0.95%	27
2015 Q1	$26.4M	Buy	36,039 +5,096	+16%	+$3.83M	0.76%	43
2014 Q4	$24.6M	Buy	30,943 +15,525	+101%	+$8.36M	0.72%	52
2014 Q3	$6.15M	Buy	+15,418	New	+$4.13M	0.19%	150

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Granahan Investment Management's TTPH Position: Q4 2016 in Review

Granahan Investment Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2016, closing a stake of 32,875 shares — an estimated $2.52M sold.

Granahan Investment Management first reported a position in TTPH in Q3 2014 and held it in 9 quarters. The position peaked at $33.5M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

Granahan Investment Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Granahan Investment Management sold 32,875 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $2.52M.
Granahan Investment Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 9 quarters.
Granahan Investment Management's Tetraphase Pharmaceuticals, Inc. position peaked at $33.5M in Q2 2015.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on Granahan Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.